Device Trial Radar · NCT03604029
Evaluating the Diagnostic Performance of ACS Using NIRS in Traumatized Lower Extremities
Last checked: Nov 20, 2026Latest source record: Sep 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
300
Planned (sponsor's estimate)
Start
Jan 7, 2019
Primary completion
Jun 30, 2021
Study completion Feb 28, 2022
Sponsor
- Lead sponsor
- Nonin Medical, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 27, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study intended to validate a new set of guidelines for a device that uses light to measure the amount of oxygen in the muscles of injured and non-injured legs and forearms in specific situations.
Conditions
- Compartment Syndrome of Leg
Interventions
Near Infrared SpectroscopyDevice
Near Infrared Spectroscopy (NIRS) sensors are applied to injured leg compartments and a control compartment to continuously measure tissue oxygenation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Acute Compartment SyndromeTime frame: Zero to seventy two hours from enrollment.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Brett A. Freedman, Col, MD
Rochester, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.